The Efficacy of a Modified Chronomodulated Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin in Advanced Colorectal Cancer (Preliminary Data)

키워드

참고문헌 (25)

1. "Randomised trial of irinotecan versusfluorouracil by continuous infusion after fluorouracil failure inpatients with metastatic colorectal cancer", pp.1407~1412 (1998)
2. "A phase II study of 5-daycontinuous venous infusion at circadian rhythm modulated rate", pp.1280~1284
3. "A chronopharmacologicphase II clinical trial with 5-fluorouracil andoxaliplatin using an ambulatory multichannel programmablepump High antitumor effectiveness against metastatic colorectalcancer", pp.893~900, Jasmin C
4. "Amulticenter evaluation of intensified chronomodulatedchemotherapy with oxaliplatin and Leucovorinas initial treatment of patients with metastatic colorectalcarcinoma", 85, pp.2532~2540 (1999)
5. "Chronomodulated versus fixed-infusion-rate deliveryof ambulatory chemotherapy with oxaliplatin andfolinic acid in patients with colorectal cancer metastases", pp.1608~1617, Jasmin C
6. "Randomised multicentred trial ofchronotherapy with oxaliplatin,fluorouracil, and folinic acid inmetastatic colorectal cancer. For the International Organizationfor Cancer Chronotherapy", 350, pp.681~686 (1997)
7. "Functional identification of the mouse circadian Clock geneby transgenic BAC rescue", 89, pp.655~667 (1997)
8. "Circadian rhythm in toxicitiesand tissue uptake of 1", 2-diammi(cyclohexane), pp.3362~1 3368
9. "Relationship betweendihydropyrimidine dehydrogenase activity and plasma 5-fluorouracillevels with evidence for circadian variation of enzymeactivity and plasma drug levels in cancer patients receiving5-fluorouracil by protracted continuous infusion", 50, pp.197~201
10. "Relationshipbetween circadian-dependent toxicity of 5-fluorodeoxyuridineand circadian rhythms of pyrimidine enzymes:possiblerelevance to fluoropyrimidine chemotherapy", 53, pp.2816~2822 (1993)
11. "Phase III multicenterrandomized trial of oxaliplatin added to chronomodulatedfluorouracil-leucovorin as first-line treatment of metastaticcolorectal cancer", 18, pp.136~147 (2000)
12. "Modulationof fluorouracil by leucovorin in patients with advancedcolorectal cancer:Evidence in terms of response rate", 10, pp.896~903 (1992)
13. "Prospectiverandomized comparison of continuous infusion offluorouracil with a conventional bolus schedule in metastaticcolorectal carcinoma:A Mid-Atlantic Oncology Programstudy", 7, pp.425~432 (1989)
14. "Efficacy of intravenous continuousinfusion of fluorouracil compared with bolus administrationin advanced colorectal cancer", 16, pp.301~308 (1998)
15. "and biotransformation of oxaliplatin", pp.5970~5976
16. "Antitumoractivity of a new platinum complex", 2-diami(cyclohexane), pp.251~260
17. "Oxalato-platinum or I-OHP An experimental and clinical appraisal andpreliminary comparison with cisplatinum and carboplatinum", pp.237~250
18. "Two consecutive phase II studies ofoxaliplatin (L-OHP) for treatment of patients with advancedcolorectal carcinoma who were resistant to previous treatmentwith fluoropyrimidines", 7, pp.95~98 (1996)
19. "Oxaliplatin as a single agent in previously untreatedcolorectal carcinoma patients: A phase II multicentric study", 9, pp.105~108 (1998)
20. "PhaseII trial of oxaliplatin as first-line chemotherapy in metastaticcolorectal cancer patients", 16, pp.2739~2744 (1998)
21. "Tumor markerCEA in monitoring of response to tegafur-uracil and folinicacid in patients with metastatic colorectal cancer", 49, pp.388~392 (2002)
22. "A phase II study of oxaliplatin combined with5-fluorouracil and leucovorin(Mayo Clinic Regimen)in5-fluorouracil refractory colorectal cancer", 34, pp.218~222 (2002)
23. "Oxaliplatin added to the simplified bimonthlyleucovorin and 5-fluorouracil regimen as second-line therapyfor metastatic colorectal cancer (FOLFOX6)", 35, pp.1338~1342 (1999)
24. "Bimonthly high-dose leucovorin, 5-fluorouracil infusion andoxaliplatin (FOLFOX3) for metastatic colorectal cancerresistant to the same leucovorin and 5-fluorouracil regimen", 9, pp.1251~1253 (1998)
25. "Multicenterphase II study of bimonthly high-dose leucovorin and oxaliplatin for metastatic colorectal cancerresistant to the same leucovorin and fluorouracil regimen", 17, pp.3560~3568 (1999)

관련 논문AI추천